Promising results with the daily oral small molecule lipoprotein(a) inhibitor, muvalaplin, in high-risk cardiovascular patients with elevated lipoprotein(a) levels
@article{ATM137644,
author = {Alpo Vuorio and Petri T. Kovanen and Frederick Raal},
title = {Promising results with the daily oral small molecule lipoprotein(a) inhibitor, muvalaplin, in high-risk cardiovascular patients with elevated lipoprotein(a) levels},
journal = {Annals of Translational Medicine},
volume = {13},
number = {2},
year = {2025},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/137644}
}